Sponsor Deadline
Posted: 4/18/2022

New Funding Opportunities within Myasthenia Gravis Network (GWU, Yale, Duke)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers (GW, Yale, Duke) partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Pilot research grants: https://www.rarediseasesnetwork.org/mgnet/pilot

Letter of intent due: December 18, 2020

Scholar Program for career development: https://www.rarediseasesnetwork.org/mgnet/scholar

Application Due: November 20, 2020

Duke’s Jeff Guptill, MD, is a member of the executive committee for the network and leads the career enhancement core.  The Duke Immune Profiling Core manages the biosamples for the network.

His contact info:

    Jeff Guptill, MD, MA, MHS, FAAN

    Associate Professor

    Director, Duke Early Phase Clinical Research Unit

    Duke Clinical Research Institute (DCRI)

    Department of Neurology - Neuromuscular Medicine

    Duke University Medical Center

    DCRI Office Phone: 919.668.0504

    Fax: 919.660.3853

    jeffrey.guptill@duke.edu

 

Funding Type
Posted
4/18/2022
Deadline
Sponsor: